• OPEN AN ACCOUNT
Indian Indices
Sensex
82,626.76 -1,048.16
( -1.25%)
Global Indices
Nasdaq
49,514.94 41.95
(0.08%)
Dow Jones
6,856.39 2.63
(0.04%)
Hang Seng
57,040.53 -599.31
(-1.04%)
Nikkei 225
10,448.94 46.50
(0.45%)
Forex
USD-INR
90.59 -0.07
(-0.07%)
EUR-INR
107.56 -0.26
(-0.24%)
GBP-INR
123.48 -0.32
(-0.26%)
JPY-INR
0.59 0.00
(0.20%)

EQUITY - MARKET SCREENER

BSE Dollex 200
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1004
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
34781876.53
EPS(TTM)
Face Value()
Div & Yield %
0
100
0
 

foseco crucible (india) ltd
Alembic Pharmaceuticals receives USFDA approval for Carbidopa, Levodopa and Entacapone Tablets
Feb 06,2026

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbidopa, Levodopa and Entacapone Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25 mg/100 mg/200 mg, 31.25 mg/125 mg/200 mg, 37.5 mg/150 mg/200 mg, and 50 mg/200 mg/200 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Stalevo Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25 mg/100 mg/200 mg, 31.25 mg/125 mg/200 mg, 37.5 mg/150 mg/200 mg, and 50 mg/200 mg/200 mg, of Orion Corporation.

Carbidopa, levodopa and entacapone tablets are indicated for the treatment of Parkinson's disease.